Literature DB >> 25186529

Are personality traits associated with white-coat and masked hypertension?

Antonio Terracciano1, Angelo Scuteri, James Strait, Angelina R Sutin, Osorio Meirelles, Michele Marongiu, Marco Orru, Maria Grazia Pilia, Luigi Ferrucci, Francesco Cucca, David Schlessinger, Edward Lakatta.   

Abstract

OBJECTIVES: Anxiety and other psychological dispositions are thought to be associated with blood pressure. This study tests whether personality traits have long-term associations with masked and white-coat effects.
METHODS: A community-based sample of 2838 adults from Sardinia (Italy) completed the Revised NEO Personality Inventory, and 7 years later, blood pressure was assessed in the clinic and with ambulatory monitoring. Logistic regressions were used to test whether anxiety, neuroticism, extraversion, openness, agreeableness, and conscientiousness predicted the white-coat and masked hypertension phenomena. Age, sex, and antihypertensive medication use were tested as moderators.
RESULTS: Significant interactions were found between personality traits and antihypertensive medications in predicting masked and white-coat effects. Only among those taking antihypertensive medication, higher anxiety was associated with a higher risk of pseudo-resistant hypertension due to white-coat effect (odds ratio 1.39, 95% confidence interval 1.01-1.91) and higher conscientiousness was associated with a lower risk of masked uncontrolled hypertension (odds ratio 0.70, 95% confidence interval 0.49-0.99). There were no significant interactions with age or sex.
CONCLUSIONS: Among those on antihypertensive medications, anxious individuals were more likely to have pseudo-resistant hypertension due to white-coat effect and less conscientious individuals were at increased risk of masked uncontrolled hypertension. Particularly among anxious and less conscientious individuals, ambulatory monitoring may improve the tailoring of pharmacological treatments.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25186529      PMCID: PMC4196211          DOI: 10.1097/HJH.0000000000000289

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  44 in total

1.  Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Lijing L Yan; Kiang Liu; Karen A Matthews; Martha L Daviglus; T Freeman Ferguson; Catarina I Kiefe
Journal:  JAMA       Date:  2003-10-22       Impact factor: 56.272

2.  Long-term risk of sustained hypertension in white-coat or masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Rita Facchetti; Fabiana Madotto; Fosca Quarti-Trevano; Hernan Polo Friz; Guido Grassi; Roberto Sega
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

3.  Introversion associated with large differences between screening blood pressure and home blood pressure measurement: The Ohasama study.

Authors:  Atsushi Hozawa; Takayoshi Ohkubo; Taku Obara; Hirohito Metoki; Masahiro Kikuya; Kei Asayama; Kazuhito Totsune; Junichiro Hashimoto; Haruhisa Hoshi; Yumiko Arai; Hiroshi Satoh; Toru Hosokawa; Yutaka Imai
Journal:  J Hypertens       Date:  2006-11       Impact factor: 4.844

4.  Personality and obesity across the adult life span.

Authors:  Angelina R Sutin; Luigi Ferrucci; Alan B Zonderman; Antonio Terracciano
Journal:  J Pers Soc Psychol       Date:  2011-09

5.  Does childhood personality predict longevity?

Authors:  H S Friedman; J S Tucker; C Tomlinson-Keasey; J E Schwartz; D L Wingard; M H Criqui
Journal:  J Pers Soc Psychol       Date:  1993-07

6.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.

Authors:  Takayoshi Ohkubo; Masahiro Kikuya; Hirohito Metoki; Kei Asayama; Taku Obara; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

7.  Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure.

Authors:  J E Liu; M J Roman; R Pini; J E Schwartz; T G Pickering; R B Devereux
Journal:  Ann Intern Med       Date:  1999-10-19       Impact factor: 25.391

8.  White coat hypertension is more risky than prehypertension: important role of arterial wave reflections.

Authors:  Shih-Hsien Sung; Hao-Min Cheng; Kang-Ling Wang; Wen-Chung Yu; Shao-Yuan Chuang; Chih-Tai Ting; Edward G Lakatta; Frank C P Yin; Pesus Chou; Chen-Huan Chen
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

9.  Hypertension awareness and psychological distress.

Authors:  Mark Hamer; G David Batty; Emmanuel Stamatakis; Mika Kivimaki
Journal:  Hypertension       Date:  2010-07-12       Impact factor: 10.190

10.  Personality traits as risk factors for stroke and coronary heart disease mortality: pooled analysis of three cohort studies.

Authors:  Markus Jokela; Laura Pulkki-Råback; Marko Elovainio; Mika Kivimäki
Journal:  J Behav Med       Date:  2013-11-08
View more
  12 in total

1.  Impact of depression on masked hypertension and variability in home blood pressure in treated hypertensive patients.

Authors:  Hiroyuki Kayano; Shinji Koba; Taiju Matsui; Hiroto Fukuoka; Kyouichi Kaneko; Makoto Shoji; Tsutomu Toshida; Norikazu Watanabe; Eiichi Geshi; Youichi Kobayashi
Journal:  Hypertens Res       Date:  2015-07-02       Impact factor: 3.872

2.  Gender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA study.

Authors:  Angelo Scuteri; Christopher H Morrell; Marco Orru'; Majid AlGhatrif; Pier Sergio Saba; Antonio Terracciano; Liana Anna Pina Ferreli; Francesco Loi; Michele Marongiu; Maria Grazia Pilia; Alessandro Delitala; Kirill V Tarasov; David Schlessinger; Antonello Ganau; Francesco Cucca; Edward G Lakatta
Journal:  Int J Cardiol       Date:  2016-05-03       Impact factor: 4.164

3.  Depression and anxiety in different hypertension phenotypes: a cross-sectional study.

Authors:  Zsófia Nemcsik-Bencze; Beáta Kőrösi; Helga Gyöngyösi; Dóra Batta; Andrea László; Péter Torzsa; Illés Kovács; Zoltán Rihmer; Xénia Gonda; János Nemcsik
Journal:  Ann Gen Psychiatry       Date:  2022-06-27       Impact factor: 3.301

Review 4.  Dysregulated Blood Pressure: Can Regulating Emotions Help?

Authors:  Claudia Trudel-Fitzgerald; Paola Gilsanz; Murray A Mittleman; Laura D Kubzansky
Journal:  Curr Hypertens Rep       Date:  2015-12       Impact factor: 5.369

5.  Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion.

Authors:  Mohammed Siddiqui; Eric K Judd; Bin Zhang; Tanja Dudenbostel; Robert M Carey; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2020-12-07       Impact factor: 10.190

6.  Evaluation of affective temperaments and arterial stiffness in different hypertension phenotypes.

Authors:  Beáta Kőrӧsi; Helga Gyӧngyӧsi; Dóra Batta; Andrea László; Illés Kovács; András Tislér; Orsolya Cseprekál; Zsófia Nemcsik-Bencze; Xénia Gonda; Zoltán Rihmer; János Nemcsik
Journal:  Hypertens Res       Date:  2020-07-17       Impact factor: 3.872

Review 7.  White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.

Authors:  Yuli Huang; Weijun Huang; Weiyi Mai; Xiaoyan Cai; Dongqi An; Zhuheng Liu; He Huang; Jianping Zeng; Yunzhao Hu; Dingli Xu
Journal:  J Hypertens       Date:  2017-04       Impact factor: 4.844

Review 8.  White coat syndrome and its variations: differences and clinical impact.

Authors:  Mariana R Pioli; Alessandra Mv Ritter; Ana Paula de Faria; Rodrigo Modolo
Journal:  Integr Blood Press Control       Date:  2018-11-08

9.  Acute emotional stress as a trigger for intraocular pressure elevation in Glaucoma.

Authors:  Kevin Gillmann; Kirsten Hoskens; Kaweh Mansouri
Journal:  BMC Ophthalmol       Date:  2019-03-08       Impact factor: 2.209

10.  The nocebo effect of drugs.

Authors:  Sara Planès; Céline Villier; Michel Mallaret
Journal:  Pharmacol Res Perspect       Date:  2016-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.